Dipivefrin Hydrochloride

Dipivefrin Hydrochloride (CAS No.: 64019-93-8) is a synthetic small molecule classified as a catecholamine prodrug analog and adrenergic pharmacology tool compound, primarily used in ocular and neuropharmacology research to study prodrug bioconversion and receptor mediated signaling, where it is hydrolyzed by esterase activity to epinephrine like active species that engage adrenergic receptor systems, with functional effects commonly associated with alpha and beta adrenergic pathways and downstream modulation of cyclic AMP dependent signaling and related second messenger responses in relevant cell based assays; within biomedical research and drug discovery workflows, it is typically applied as a reference molecule for investigating corneal or tissue esterase dependent activation, transporter and permeability behavior, receptor response profiling, and comparative structure activity trends among sympathomimetic analogs, while reported in vitro pharmacological effects are generally described qualitatively in the nanomolar to micromolar range depending on assay format, receptor context, and enzymatic conversion efficiency, and experimental use in cell models, ex vivo ocular tissues, and animal based pharmacology models is selected according to study design, with the concentrations or doses used in experiments typically depending on specific experimental designs and research objectives.